Stay updated on GB5121 in Refractory CNS Lymphoma Clinical Trial

Sign up to get notified when there's something new on the GB5121 in Refractory CNS Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GB5121 in Refractory CNS Lymphoma Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The page revision updated from v3.5.2 to v3.5.3, signaling a new version of the page. This indicates a minor patch rather than any substantive changes to the study details.
    Difference
    0.1%
    Check dated 2026-04-30T17:38:35.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    Updated the location naming for the France region from "Nouvelle-Aquitaine"/"Bordeaux, Nouvelle-Aquitaine" to "New Aquitaine"/"Bordeaux, New Aquitaine" for this study’s sites.
    Difference
    0.1%
    Check dated 2026-04-23T14:37:07.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page shows an updated revision tag: Revision: v3.5.2, replacing Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-16T10:51:57.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    49 days ago
    Change Detected
    Summary
    Revision history updated to add Revision: v3.5.0 and remove Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T15:45:04.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    - Revision updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.1%
    Check dated 2026-03-11T16:52:04.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    A new Revision: v3.4.2 appears, and the prior operating-status notice regarding government funding has been removed; these changes are administrative and do not alter the study information.
    Difference
    0.4%
    Check dated 2026-02-11T11:15:33.000Z thumbnail image

Stay in the know with updates to GB5121 in Refractory CNS Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GB5121 in Refractory CNS Lymphoma Clinical Trial page.